Webinar: «Calprotectin, a new routine inflammation biomarker»

03. Feb 2022 | 3 min read

Webinar: «Calprotectin, a new routine inflammation biomarker»

Webinar with Dr Camille Chenevier-Gobeaux from Assistance publique - Hôpitaux de Paris

This webinar was sent live 8th February 2022. You can watch the recording here. 

Calprotectin is a novel inflammation biomarker with diagnostic value in various infectious and inflammatory conditions. Calprotectin for plasma and serum is gaining more interest and is today also in routine use at various hospitals and laboratories across Europe. Speaker Dr Camille Chenevier-Gobeaux from Assistance publique - Hôpitaux de Paris, will in this webinar highlight the distinctive clinical value of calprotectin whilst sharing her experience from implementing the marker into clinical routine at the APHP hospitals.

This webinar is especially noteworthy for laboratory professionals and clinicians who are already familiar with plasma and serum calprotectin, and that are curious to learn more from the experience of routine customers of the Gentian Calprotectin GCAL®.

 

New call-to-action

 

If you want to learn more about the biomarker calprotectin and the Gentian GCAL® assay please find more information on our product page and detailed articles.

 

Contact us for further information

Explore GCAL® in your laboratory - fill out the form or send an email to marketing@gentian.com for more information about the product and prices.

 

 

New call-to-action

You may also read


The canine-specificity of the Gentian Canine CRP Immunoassay

Dec 02, 2024

The canine-specificity of the Gentian Canine CRP Immunoassay

The Gentian Canine CRP Immunoassay is used for quantitative determination of canine CRP in plasma and serum..

Discover the power of calprotectin testing in rheumatology – CECR 2024

Dec 02, 2024

Discover the power of calprotectin testing in rheumatology – CECR 2024

Gentian Diagnostics is excited to announce our participation in the Central European Congress of Rheumatology..

Newsletter: Circulating calprotectin - the power to assess inflammation

Nov 13, 2024

Newsletter: Circulating calprotectin - the power to assess inflammation

Circulating calprotectin - the power to assess inflammation 3/2024 With the growing demand for circulating..